CV in English by mikeholy

VIEWS: 892 PAGES: 21

									                                     HAO, Wei, MD., Ph.D.

                                       Professor of Psychiatry
                  Director of WHO Collaborating Center for Drug Abuse and Health
                                 Co-director of mental Health Institute
                         Central South University (Hunan Medical University)
                                       Tel: +86-731-85292156
                                       Fax: +86-731-85360160
                                    Email: weihao57@gmail.com

PERSONAL DATA

Name:               Wei HAO
Gender:             Male
Place of Birth:     Anhui Province, P.R.CHINA.
Data of Birth:      May 25, 1957
Citizenship:        People's Republic of China
Marital Status:     Married

PREVIOUS POSTS

Medical Officer
Mental Health and Substance Abuse Control
Western Pacific Regional Office
World Health Organization
Manila, Philippines

EDUCATION & DEGREE/DIPLOMA

                    Medical Student, Faculty of Clinical Medicine,      Medical Doctor‟s Degree
1977.7-1982.8
                    Anhui Medical College                               granted

                    Postgraduate Student, Mental Health Institute,      Postdoctoral research
1984.8-1987.8
                    Hunan Medical University.                           certification granted

                    Trainee, Japanese Extensive Training Course,
                    Beijing Language Institute, Beijing
                    Visiting scholar, Dept of Psychiatry & Neurology,
                    Hamamatsu Medical University (Japan)
                                                                    Postdoctoral training
1990.8-1996.5
                    Trainee, U.S. Drug Abuse Prevention Workshop by certifications granted
                    U.S. Center for Substance Abuse Prevention.
                    Trainee, Training Course of Drug Abuse Prevention
                    Activities by Ministry of Health and Welfare and
                    Drug Abuse Prevention Center, Japan.

1993.9-1996.7       Institute of Mental Health, Central South University Ph.D. granted
                    (Hunan Medical University)
Hao Wei, MD, Ph.D.                                                                    VITA, 2002


PROFESSIONAL MEMBERSHIP AND ACADEMIC EXPERIENCE

1. Honorary President, Hunan Behavioral Medicine Association
2. President, Chinese Psychiatrist Association
3. Member, Standing Committee of Chinese Psychiatry Association, Chinese Neuroscience
   Association
4. Director, Department of R & D, National Mental Health Center, CDC
5. Vice President, Chinese Drug Abuse Treatment and Prevention Association
6. Assistant Editor, Addiction
7. Vice Chief editor, Chinese Journal of Drug Dependence.
8. Vice Chief Editor, Chinese Journal of Drug Abuse Treatment and Prevention
9. Member of Editorial Board in fiver Chinese Journals (Referential Journal of Foreign Psychiatry,
   Journal of Practice Psychiatry, Journal of Physician, Chinese Journal of Behavioral Medical
   Science, Medicine Section of Bulletin of Central South University)
10. Founding and Active Member, The International Society of Addiction Medicine
11. Member, Scientific Advisory Committee on Tobacco Production Regulation, World Health
    Organization
12. Board Member, Administration Council of Medical Association of Hunan Province.
13. Member, Expert Committee on Mental Health, Ministry of Health.
14. Board Member, Chinese Association of Toxicology.
15. Member, National Examination Committee on Qualification of Health Professionals, Ministry of
    Health.
16. Member, Evaluation Committee on National Medical Scientific Research Reward and National
    Young Medical Professional Reward, Chinese Medical Association (2001-2006).
17. Member, WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems
18. National Focal Point for China for the implementation of Regional Strategy to Reduce
    Alcohol-Related Harm in the Western Pacific Region, WHO.
19. Chair, Education Committee of Asian-Pacific Society for Alcohol and Addiction Research
    (APSAAR)

NATIONAL AND INTERNATIONAL ACADEMIC ACTIVITIES

1. Contributor, Drafting neurosis and psychoactive substance use related disorders in Chinese
   Classification and Diagnostic Criteria on Mental Disorder.
2. Participator, ICD-10 field trial in China
3. Contributor, Women and Substance Abuse, 1993 Country Assessment Report, WHO/PSA
4. Consultant: Rehabilitation and Relapse Prevention of Drug Abuse Program and Social Skills
   Training Program in Chinese Correctional Institutes
5. Temporary consultant for WHO Consultation on Alcohol Epidemiology in Developing Societies
6. Reviewer and Contributor, WHO/PAS Global Alcohol Database Project
7. Reviewer, the Draft of Mental Health Legislation in China
8. Project Reviewer, National Major Projects on Mental Health, National Scientific Committee
9. Project Reviewer, Projects of National Nature Scientific Research Foundation


                                                                                                     2
Hao Wei, MD, Ph.D.                                                                       VITA, 2002


10. Reviewer, Global Charter, International Center for Alcohol Policy
11. Contributor, Drinking Problems in Developing Countries
12. Project participants, Instrumental use of Amphetamine typed stimulants (ATSs), WHO/Substance
    Abuse Department.
13. Short-term Consultant for WHO. Mental health status in Vietnam, Sept. 30-Oct. 21, 2003.
14. Short-term Consultant for WHO. Invited lecturer of WHO training course on early recognition and
    intervention of psychosis. Hanoi, Vietnam. 14-16 Oct, 2003.
15. Temporal Consultant for WHO. 4th WHO/CHINA Workshop on Addictive Behavior, Nov. 16-21,
    2003.
16. Medical Officer. First SPC/WHO Meeting on Alcohol and Health in Pacific Countries. New
    Caledonia, Sept. 28-30, 2004.
17. Temporal Consultant for WHO. Consultative Meeting on Alcohol and Public Health. Geneva. Jun
    7-9, 2005.
18. Member of WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems

GRANTS (FROM 1990-)

1. Principal Investigator, Mental Health Okamoto Memorial Foundation, “Cross Culture Study on
   Neurotic Patients In Chinese And Japanese". 500,000 Japanese Yuan (5000 US$) 50%,
   2/1990-2/1992.
2. Principal Investigator, China Medical Board of New York Inc., "Prevention and Treatment of Drug
   Abuse in China", 120,000 US$, 20%, 6/1992-10/1996.
3. Principal Investigator. China Education Committee, "Epidemiological Study on Opiate Use in
   China", 50,000 RMB (6000 US$) 100%, 10/1992-10/1993.
4. Principal Investigator. World Health Organization. "Women and Substance Abuse in China
   (country report)". 2,000 US$, 100%, 6/1993-6/1994.
5. Principal Investigator. National Natural Science Foundation. “QOL Questionnaire Development
   and QOL in General Population in China” 80,000 RMB (10000 US$), 20%, 6/1994-1997.
6. Participator. National Natural Science Foundation. “The Chinese Taoism on the Treatment of
   Neurotic Patients: Principle and Mechanism” 80,000 RMB (10000 US$), 10%, 6/1995-1998.

7. Principal Investigator. China Medical Board of New York Inc., “Substance Abuse in China”” ,
   260,000 US$, 100%, 6/1996-6/2001.
8. Principal Investigator. Mental Health Okamoto Memorial Foundation, “Comparison Study on
   Taoism Cognitive and Morita Therapy” 1,500,000 Japanese Yuan (14,000 US$), 50%,
   8/1996-8/1997.
9. Principal Investigator. PSA/WHO “Alcohol Data Bank (Country report)” 2,000 US$, 100%,
   2/1997-8/1997.
10. Principal Investigator. State Foundation for New Drug of Research and Development, “Research
    and Development of New Detoxification Chinese Herb Medicine for Opiate Abuse” 50,000 RMB
    (6,000 US$) 100%, 2/1998-12/2001.
11. Principal Investigator. National Chinese Medicine Administration Bureau. “Screening Tests on
    Chinese Herbs on Detoxification Treatments of Opiate”, 80,000 RMB (6,400 US$), 100%,
    8/1996-8/1997.
12. Principal investigator. International Center for Alcohol Policy. “Chinese Translation and Peer
    Review of Global Charter on Alcohol”, 1200 US$, 100%, 1999.



                                                                                                      3
Hao Wei, MD, Ph.D.                                                                       VITA, 2002


13. Principal Investigator. „95‟ Major Project of State Science and Technology Committee of China.
    “The Effectiveness of Chinese Herb Medicine on Detoxification Treatment of Opiate Abuse:
    Clinical and Experiment Researches.” 420,000 (55,000 US$), 60%, 1996-2000.
14. Principal Investigator. Substance Abuse Department/WHO. Rapid Assessment and Response of
    Amphetamine-typed Stimulants Use, 5,000US$, 100%, 2000-2002.
15. Principal Investigator. Substance Abuse Department/WHO. 10,000US$, 100%, WHO
    Collaborative Study on Alcohol Involvement in Injuries. 2001-2002.
16. Principal Investigator. WHO Project on Unrecorded Alcohol Consumption/WHO, 10,000 US$,
    100%, 2001-2003.
17. Principal Investigator. Consultation Meeting on Development and Adaptation of Guidelines and
    Curricula for Mental Health Education and Training/ WHO 40000 US$, 100%, 2002.
18. Principal Investigator. Morphine dependence and relapse related neuroadaptation mechanism.
    National Science Foundation. 200,000 RMB, 100%, 2003-2005.
19. Co- Investigator. Biological mechanism of psychoactive substance dependence and related
    prevention and treatment. National Basic Science Program, 22 million RMB, 10%, 2003-2008.
20. Principal Investigator. National epidemiological survey on illicit drug, (Hunan area). National
    Narcotic Committee, 260,000 RMB, 100%, 2004-2006.
21. Co-investigator. National 11.5 Program. Evaluation of national anti-drug work. Ministry of
    Science and Technology, 3,600,000 RMB, 10%, 2007-2010.
22. Principal Investigator. National 11.5 Program. Development of community based, “seamlessly
    connected” and integrated model for drug abuse, Ministry of Science and Technology, 2,000,000
    RMB, 100%, 2007-2010.
23. Principal Investigator. Pilot study of an epidemiological survey on alcohol use and related
     harms in China, WHO, RMB 71,000 100%, 2009-2010.

HONORS AND AWARDS

1. Science and Technology Progress Award: “Series of Behavioral Medicine Research” awarded by
   National Science and Technology Committee as an Excellent Project in 1994 (The Third Grade).
2. Excellent Paper Award. “Effect of Clonidine on Cigarette Cessation and in the Alleviation of
   Withdrawal Symptoms” awarded by WHO and Chinese Mental Health Association for Young
   Professional in Mental Health, in 1989 (The Second Grade).
3. Excellent Paper Award. “Psychoactive Substance Use in Three Sites of China: Gender Differences
   and Related Factors” awarded by Hunan Provincial Science and Technology Committee in 1996
   (The First Grade).
4. Science and Technology Progress Award: “Program of National Epidemiological Study on
   Substance Abuse” awarded by Hunan Provincial Science and Technology Committee in 1996 (The
   Second Grade).
5. Leading Scientist in University Award. Awarded by Hunan University Working Committee, 1998.
6. Excellent Paper Award. “Alcohol consumption and alcohol-related problems: Chinese experience
   from six area samples”(Addiction 94:1567-1476, 1999), Hunan Medical Association.
7. The State Counsel Special Contribution Award for Excellent Researcher in Medical Science, 1999,
   The State Counsel, China.

International Meeting Participated
1.      X World Congress of Psychiatry, Madrid, Spain, 23-28 August 1996.



                                                                                                      4
Hao Wei, MD, Ph.D.                                                                    VITA, 2002


2.       Training Course of Drug Abuse Prevention Activities, 21 October –15 November
      1996.
3.       XIV Congress of the World Association for Social Psychiatry, Vancouver, British
      Columbia, Canada, August 16-21, 1998
4.       World Health Organization Consultation on Alcohol Epidemiology in Developing
      Societies, Mexico City, Mexico, 13-15 August 1998.
5.      Second Regional Meeting on the Proposed Draft Global Charter on Alcohol,
      Bangalore, India, 8-9 June 1999.
6.      WHO Meeting on Amphetamines, MDMA, and other Psychostimulants, Phase II,
      Bangkok, Thailand, 22-26 November 1999.
7.       International Meeting on Draft Global Charter on Alcohol, Geneva, 10-12 May 2000.
8.      WHO Experts Meeting on Minimal Risk Distribution for Alcohol, Geneva,
      Switzerland, 1-11 May 2001.
9.      First Meeting of WHO Scientific Advisory Committee on Tobacco Product
      Regulation (SACtob), WHO Headquarters, Geneva, Switzerland, 12-13 October 2000.
10.     Second Meeting of WHO Scientific Advisory Committee on Tobacco Product
      Regulation (SACtob), Atlanta, USA, 31 January-2 February 2001.
11.     Third Meeting of WHO Scientific Advisory Committee on Tobacco Product
      Regulation (SACtob), Penang, Malaysia, 4-6 July 2001.
12.      Health Care, East and West, Moving into the 21st Century, Boston, USA, 24-29 June
      2001.
13.      PRCP Meeting, Melbourne, Australia, 5-11 Oct, 2001.
14.      WHO Workshop on Serial Training for Rehabilitation and Demand Reduction
      Program, Kunming, China, 9-16 Dec, 2001
15.     Fourth Meeting of WHO Scientific Advisory Committee on Tobacco Product
      Regulation (SACtob), Oslo, Norway, Feb, 4-9, 2002.
16.      Seminar on ATS Treatment, Rehabilitation and Research (hosted by Colombo Plan),
      Singapore, April 15-19, 2002.
17.      XII World Congress of Psychiatry, Yokohama, Japan, Aug 23-Sept 1. 2002.
18.      WHO/Beijing Workshop on Substance Abuse: Prevention, Treatment Rehabilitation.
      Beijing, Sept. 9-13, 2002.
19.      First China International Symposium on Alcohol and Health, Shanghai, Sept. 15-18,
      2002.
20.      WHO Meeting on Mental Health Education and Training, Changsha, Nov., 21-26,
      2002.(Organizer)
21.      The Forth WHO/China Workshop on Addictive Behavior, Changsha, China. Nov.
      16-21 , 2003. (Organizer).
22.      First SPC/WHO Meeting on Alcohol and Health in the Pacific, Noumea, New
      Caledonia, 28-30th September 2004




                                                                                                   5
Hao Wei, MD, Ph.D.                                                                       VITA, 2002


23.      International Conference on Tackling Drug Abuse, Hong Kong, 23 to 25 February
      2005.
24.      WHO Consultative Meeting on Alcohol and Public Health, Geneva, Jun 7-9, 2005.
25.      48th Annual Conference on Neurochemistry Fukuoka, Japan, Sept 28-30, 2005.
26.      Sino-US Forum on Mental Health, Changsha, China. Oct. 17-19, 2005 (Organizer)
27.     18th European Congress of European College of Neuropsychopharmacolgy,
      Amsterdam, Netherlands, Oct. 22-25, 2005.
28.      The Fourth Pan-Asia Pacific Conference on Mental Health, Shanghai, Nov. 14-17,
      2005.
29.     The Fifth WHO/China Workshop and Training Course on Addictive Behavior,
      Changsha, China. Dec. 2-12, 2005. (Organizer).
30.     Temporary Advisor: Technical Consultation on the Development of a Strategy to
      Reduce Alcohol-Related Harm. 15-17 March 2006, Manila, Philippines.
31.      Invited speaker: 17th International Conference on the Reduction of Drug Related
      Harm. April 30-May 4, 2006, Vancouver, Canada.
32.      Temporary Advisor and Panel meeting Chare: WHO Collaborative Research Project
      on Drug Dependence Treatment and HIV/AIDS. 29 May-02 June 2006, Beijing.
33.      Chair: Symposium of Alcohol-related problems: international public health and
      policy issues, in ISBRA 2006 World Congress, Sydney, Australia, 10-13 September
      2006.
34.     Invited discussant: ISBRA Satellite meeting, Alcohol Use Disorders: The Diagnostic
      Conundrum ISBRA Satellite Meeting, 14-15 September 2006, Sydney.
35.     Advisor: WHO Meeting with Stakeholders on Health Problems Related to Alcohol
      Consumption. Oct 9, 2006, Geneva, Switzerland.
36.      Advisor: WHO Expert Committee on Problems Related to Alcohol consumption. Oct
      10-13, 2006, Geneva, Switzerland.
37.      Invited speaker: Drinking and drinking-related problem in China Asian-Pacific
      Society for Alcohol and Addiction Research (APSAA), Sept. 28-30,2007. Ohtsu, Japan.
38.     Plenary speaker: Improving drug treatment in China. World Psychiatric Association
      Regional Conference, Sept 20-23, 2007. Shanghai, China.
39.      Symposium Chair: Co-morbidity of substance use and bipolar disorder. World
      Psychiatric Association Regional Conference, Sept 20-23, 2007. Shanghai, China.
40.      Symposium speaker: Alcohol dependence and drinking-related harms. World
      Psychiatric Association Regional Conference, Sept 20-23, 2007. Shanghai, China.
41.      Symposium Chair: Mental health service in general hospitals. World Psychiatric
      Association Regional Conference, Sept 20-23, 2007. Shanghai, China.

42. Consultant. WHO Regional Technical consultation on the global strategy to reduce the harmful use of
    alcohol. Auckland, New Zealand. 24-26 March 2009.
43. Consultant. WHO. Meeting for International research on alcohol, health and development, Stockholm,
    24-25 September 2009



                                                                                                      6
Hao Wei, MD, Ph.D.                                                                        VITA, 2002


44. Invited participant. Minister for Elderly Care and Public Health, Sweden Government. The first Global
    Expert Meeting on Alcohol, Health and Social Development, Stockholm, Sweden, 22 to 23 September
    2009.

PUBLICATIONS

Books
1.    Hao W, Young DS, Menstrual madness. In: Robert L. Spitzer et al (ED).DSM-III
   Case. Book. pp. 401-402. American Psychiatric Press Inc. Washington DC. 1989.
2.       Hao W. Neuroses: In Young, DS (Ed). Manual on Classification and Diagnostic
      Criteria of Mental Disorders and Case Book, Hunan University Press. Changsha, 1989.
3.       Hao W, Young DS, Chen XY. Psychotherapy and counseling. In: Young, D (Ed).
      Textbook of Behavioral Medicine. pp. 248-271, Hunan University Press. Changsha,
      1990.
4.       Hao W, Deng YL. Psychoactive substance abuse. In: Young DS.(Ed) Textbook of
      Behavioral Medicine. pp. 64-71, Hunan University Press. Changsha, 1990.
5.       Hao W, Cognitive therapy, psychoanalysis therapy, client center therapy, and Morita
      therapy. In Young D. (Ed). The Foundation of Psychiatry. pp. 650-681, 697-699 Hunan
      Science & Technology Press, 1995.
6.       Hao W (Chief editor). Substance abuse, pp. 75-90, Classification of Mental Disorders,
      pp. 15-30. In: Postgraduate Training of Psychiatry. Hunan Science & Technology Press,
      1998.
7.       Hao W. Neurosis, Psychosis, and Alcohol and Drug Abuse. In: Wu ZQ (Ed) A
      Comprehensive Textbook of Medicine for General Practitioners in Countryside. pp.
      652-682, People‟s Health Press, Beijing, 1998.
8.       Hao W. Drug Abuse, and psychotherapy and life skills training. In: Young & Li (Eds.)
      Textbook of Behavioral Medicine (2nd). pp. 231-257, 539-548, 563-601.Hunan Science
      & Technology Press, 1998.
9.       Hao W. Classification of neurosis, and psychotherapy. In: Zhang YL (Ed) Neurosis:
      Theory and Practice, 2000.
10.      Hao W (Ed in chief). Psychiatry training. Hunan Science & Technology Press, 1999.
11.      Hao W. Classification on mental health, psychoactive substance abuse and toxic
      psychosis. In Xu TY (Ed), Modern Psychiatry. PP. 69-74, 246-271, Shanghai University
      Press, Shanghai, 2000.
12.      Hao W. Psychotropic drugs. In; Wu ZQ (ed). Textbook of Clinical Pharmacology, PP.
      622-638, Beijing, People‟s Health Publishing House, 2001.
13.      Hao W. Substance intoxication and emergency treatment. In Li HD (ed) Drug
      Therapy. PP. 231-243, Beijing, People Health Publish House, 2001.
14.      Hao (Ed in chief)). Textbook of Psychiatry (4th edition)(the national unified textbook
      for all medical university student in China, assigned by authority of Health Ministry,
      China), People’s Medical Publishing House, Beijing, 2001.

15.      Hao W. Tobacco dependence. In; Shen YC (ed). Textbook of Psychiatry (4th edition).
      People Health Publish House, Beijing. PP 231-243, 2002.




                                                                                                       7
Hao Wei, MD, Ph.D.                                                                        VITA, 2002


16.      Hao W (Ed in chief). National Examination Series Books, Psychiatry. Scientific and
      Technical Documents Publishing House, Beijing, 2002.
17.      Hao W., Young DS., Xiao SY et al. Drinking patterns and related problems in a large
      general population sample in China. In: Demers A. et al. (ed). Surveys of drinking
      patterns and problems in seven developing countries. Department of Mental Health and
      Substance Dependence/WHO, PP 115-130, 2001.
18.      Hao W. Addictive behavior and related management. In National Expert Examination
      Committee on Medicine (Eds) Examination Guideline for Psychiatry and Psychology.
      Beijing, Knowledge Publishing Press. 2002.
19.      Hao W. Substance related disorders. In: Shen UC, Yu X (eds) Textbook of Psychiatry,
      PP 112-137, Beijing, Beijing Medical University Press, 2002.
20.      Liu TQ, Hao W. The outline and examination questions of textbook of psychiatry.
      People Health Publish House, Beijing. 2003.
21.      Hao W. Psychoactive substances and other toxic substances related mental disorders.
      In Chen YF, Li SW (eds) Diagnosis and treatment of brain disorders. Peking Union
      Medical College Publishing Press. PP 1090-1138, 2003.
22.      Hao W, Wang XP. Collection of medical examination test questions for psychiatry.
      People‟s Military Medical Press. 2003.
23.      Hao (Ed in chief)). Textbook of Psychiatry (5th edition)(the national unified textbook
      for all medical university student in China, assigned by authority of Health Ministry,
      China), People‟s Medical Publishing House, Beijing, 2004.

24.      Hao W. Reward and addiction. In: Ju G et al. (eds) Textbook of neurobiology for
      postgraduates. PP. 543-557, People‟s Medical Publishing House, Beijing, 2004.

25.     Hao W. Substance related disorders. In Jiang KD. Textbook of Psychiatry, People’s
      Medical Publishing House, Beijing, 2005.
26.      Hao. W. Detoxification treatment. In. Zhang MY (ed) Clinical standard technique:
      psychiatry section, PP 61-64. PMMP Publication, Beijing,2006.
27.       Hao W. Psychoactive substance related disorders. In Zhang MY (ed) The Guidance of
      clinical diagnosis and treatment, Psychiatry section. PP 21-38. People ’s Medical
      Publishing House, Beijing, 2006.

28.      Hao W (Ed in chief). Case file, Psychiatry (Bilingual textbook of psychiatry). People’
      s Medical Publishing House, Beijing, 2007.
29.      Hao W. Mental Disorders. In. Zou HJ et al. (eds) Textbook of Internal Medicine, PP.
      703-737. People‟s Medical Publishing House, Beijing 2007.
30.      Hao (Ed in chief)). Textbook of Psychiatry (6th edition)(the national unified textbook
      for all medical university student in China, assigned by authority of Health Ministry,
      China), People‟s Medical Publishing House, Beijing, 2008.
31.      Liu TQ, Hao W, Yu X (ed in chief) . Collection of medical examination test questions
      and learning instruction for psychiatry. People‟s Medical Publishing House, Beijing,
      2008.
32.     Hao W. Behavioral Medicine (2 edition), Hunan Science and Technology Publishing
      House, 2008.



                                                                                                       8
Hao Wei, MD, Ph.D.                                                                         VITA, 2002


33.      Hao W. Opiate and other substance us-related mental disorders. In Shen YC(Eds).
      Psychiatry, People‟s Medical Publishing House, Beijing, 2009
34.      Hao W, Yu X, Xu YF (eds in chief). The textbook of standard diagnosis and treatment
      on mental disorders, Peking University Medical Press, Beijing, 2009.
35.      Hao W, Liu TQ (eds in chief) The selected problem set in psychiatry for national
      examination of health professionals, People‟s Medical Publishing House, Beijing,2009
36.      Cao D, Hao W. Addiction, learning and memory, In: Ch JP (ed) New development in
      Psychiatry, People‟s Military Medical Press, Beijing, 2009.
37.       Wang CS, Hao W. Dopamine system and susceptibility of addiction. Addiction,
      learning and memory, In: Ch JP (ed) New development in Psychiatry, People‟s Military
      Medical Press, Beijing, 2009.
38.      Hao W. Psychiatric epidemiology, In Jiang KD (ed). Textbook of Psychiatry for
      Postgraduates. People‟s Medical Publishing House, Beijing,2009.
39.      Hao W. Substance use. In Jiang KD (ed). Textbook of Psychiatry for Postgraduates.
      People‟s Medical Publishing House, Beijing, 2009.

International Publications
Journal papers
40.    Hao W, Young DS. Effect of clonidine on cigarette cessation and in the alleviation of
    withdrawal symptoms. British Journal of Addiction. 83(10): 1221-1226.1988 (English).
41.      Hao W, Xie DW, Miyasato K. et al. Management of tobacco dependence. Japanese
      Journal of Clinical Psychiatry. 20(6):136-141,1991 (Japanese).
42.      Hao W, Xie DW. Morita therapy on 15 refractory neurotic patients. Journal of Morita
      Therapy 2(3): 221-225, 1992 (Japanese).
43.      Hao W, Young DS and Li LJ et al. Woman substance use in China. In Women and
      Substance Abuse, 1993 Interim Report, WHO, 1994 (English).
44.       Hao W, Young DS and Li LJ et al. Psychoactive substance use in China: Gender
      differences and related factors. Addiction. 90:1505-1517, 1995 (English).
45.      Hao W. Commentary: Alcohol use and public good, a Chinese view. Addiction,
      90:1448-1450, 1995 (English).
46.      Hao W, Young D. Psychoactive substance us in three sites in China. Psychiatry and
      Clinical Neurosciences. 52:s324-s328, 1998 (English).
47.      Hao W, Young D. Alcohol consumption and alcohol-related problems: Chinese
      experience from six area samples, 1998. Addiction 94:1567-1576, 1999.(English)
48.       Hao W, Young D. Drinking pattern and problems in China.. (invited author) Journal
      of Substance Use. 5:71-78, 2000 (English)
49.      LI LJ, Young DS, Hao W. The relationship between objective life status and
      subjective life satisfaction with quality of life. Behavioral Medicine. 23: 149-159, 1998.
50.      Hao W, Zhao M. A Comparative clinical study of the effect of WeiniCom, a Chinese
      herbal compound, on alleviation of withdrawal symptoms and craving for heroin in
      detoxification treatment. Journal of Psychoactive Drugs, 32:277-284, 2000 (English).




                                                                                                        9
Hao Wei, MD, Ph.D.                                                                         VITA, 2002


51.      Zhao M., Hao W. Yang D. et al. A modified therapeutic community-based
      rehabilitation programme for heroin dependence in reformatory school: A follow-up
      study. The Drug and Alcohol Professional. 2: 10-19, 2002 (English).
52.      Liu PZ, Yue WH, Hao W.et al. Characteristics and risk factors of psychosomatic
      symptoms related to female tubal sterilization in rural area in Hunan Province, China: A
      Prospective study. Reproduction & Contraception. 13:37-52, 2002.(English)
53.        Hao W, Xiao SY, Liu TQ, et al. The second National Epidemiological Survey on
      illicit drug use at six high-prevalence areas in China: prevalence rates and use patterns.
      Addiction, 97, 1305–1315, 2002. (English).
54.       Yue WH. Hao W. Liu PZ. et al. A case control study on psychological symptoms in
      sleep apnea-hypopnea syndrome. Canadian Journal of Psychiatry. 48: 318-323,
      2003.(English) (Corresponding author)
55.      Cochrane J, Chen HH, Conigrave KM, and Hao W. Invited review, alcohol use in
      China. Alcohol & Alcoholism 38: 537-542, 2003. (English)
56.      Hao H., Su ZH, Xiao SY et al. Longitudinal surveys of prevalence rates and use
      patterns of illicit drugs at selected high-prevalence areas in China from 1993 to 2000.
      Addiction, 99, 1176–1180, 2004
57.      Hao W., Su ZH, Liu BL et al. Drinking and drinking patterns and health status in the
      general population of five areas of China. Alcohol & Alcoholism. 39: 43-52, 2004
      (English)
58.      Liu XB, Li Yi, Zhou L., Chen HX., Su ZH., Hao W. Conditioned place preference
      associates with the mRNA expression of diazepam binding inhibitor in brain regions of
      the addicted rat during withdrawal. Molecular Brain Research 137: 47-54, 2005.
      (English) (Corresponding author)
59.      Hao W., Chen H., Su ZH. National Experiences: China, Alcohol today. Addiction 100:
      737-741, 2005 (English)
60.     Hao W. Commentary: Supply reduction does work: the case from Australia.
      Addiction 100: 926-927, 2005 (English)
61.      Hao W. the molecular and cellular basis of non-dopamine system in addiction
      (abstract). Bulletin of the Japanese society for Neurochemistry. 44: 158, 2005 (English)
62.      Cherpitel CJ, Ye Y, Bond J, Rehm J, Poznyak V, Macdonald S, Stafström M, and Hao
      W. Multi-level analysis of alcohol-related injury among emergency room patients: a
      cross-national study. Addiction, 100:840-1850, 2005.
63.      Dong ZF, Han HL, Wang MN, Xu L, Hao W. Morphine conditioned place preference
      depends on glucocorticoid receptors in both hippocampus and nucleus accumbens.
      Hippocampus 2006, 16:809–813. (English) (Corresponding author)

64.      Cui MH, Yang Y, Yang JL, Zhang JC, Han HL, Xu L, Hao W. Enriched environment
      experience overcomes the memory deficits and depressive-like behavior induced by
      early life stress. Neuroscience Letters 2006, 404: 208–212. (English) (Corresponding
      author)
65.      Zhou XH., Su ZH., Deng HQ., Xiang XJ., Chen HX., Hao W. A comparative survey
      on alcohol and tobacco use in urban and rural populations in the Huaihua District of
      Hunan Province, China Alcohol 2006, 39 , 87-96 (English) (Corresponding author)




                                                                                                        10
Hao Wei, MD, Ph.D.                                                                         VITA, 2002


66.       Cherpitel CJ, Bond J, Ye Y, Borges G, Room R, Poznyak V, Hao W. Multi-level
      analysis of causal attribution of injury to alcohol and modifying effects: data from two
      international emergency room projects. A research report from the Emergency Room
      Collaborative Alcohol Analysis Project (ERCAAP) and the WHO Collaborative Study
      on Alcohol and Injuries. Drug and Alcohol Dependence, 82: 258-268, 2006.
67.       Li Y, Liu XB, Chen HX, Deng HQ, Xiang XJ, Chen HH & Hao W Development,
      extinction and reinstatement of morphine withdrawal-induced conditioned place
      aversion in rats. Addiction Biology, 2007, 12, 470–477 (English) (Corresponding author)
68.      Tang YL., Hao W. Improving drug addiction treatment in China. Addiction, 2007,
      102, 1057–1063. (English) (Corresponding author)
69.      Zhang DK, Zhou XH, Wang XY, Xiang XJ, Chen HX & Hao W. Morphine
      withdrawal decreases responding reinforced by sucrose self-administration in
      progressive ratio. Addiction Biology, 2007 12, 152–157 (English) (Corresponding
      author)
70.      Zhang DK, Zhou XH., Wang XY, Xiang XJ., Chen HX, Hao W. Morphine
      withdrawal decreases responding reinforced by sucrose self-administration in
      progressive ratio. Addiction Biology, 2007, 12: 152–157. (English) (Corresponding
      author)
71.      Zhou XH, Zhang DK., Hao W. A case of dependence on the combination use of
      sublingual buprenorphine, scopolamine, and promethazine. Addictive disorders & their
      Treatment, 2007 in press. (Corresponding author)
72.      Yue WH; Liu HG, Liu PZ, Hao W. Association Study of Serotonin Transporter Gene
      Polymorphisms with Obstructive Sleep Apnea Syndrome in Chinese Han Population.
      Sleep, 2008, 31, 1535-1541. (Corresponding author)
73.      Liu HH, Li L, Hao YH, Cao D, Xu L, Rohrbaugh R, Xue ZM, Hao W et al. Disrupted
      white matter integrity in heroin dependence: a controlled study utilizing diffusion tensor
      imaging. The American Journal of Drug and Alcohol Abuse, 2009, 34:562-575.
74.       Wang YH, Zhang FQ, Tang S, Lai MJ, Hao W., et al. Lack of effect of habenula
      lesion on heroin self-administration in rats. Neuroscience Letters 2009, 461: 167–171.

75. Yang Z.Shao, YC. Li SJ. Qi JL. Zhang MJ. Hao W. Jin GZ. Medication of
    l-tetrahydropalmatine significantly ameliorates opiate craving and increases the
    abstinence rate in heroin users: a pilot study. Acta Pharmacologica Sinica 2008, 29:
    Vol.29(No.7)
76.       (Corresponding author)

International conference papers

77.      Hao W. Alcoholism in China. In: Symposium of the Management of Alcoholism,
      Shizuoka, Japan. 1991.2 (Japanese).
78.       Hao W, Xie DW. Miyasato, K. et al. Early and late-onset depression: A
      re-examination, The 4th Asia/Oceania Regional Congress of Gerontology. Yokohama,
      Japan. 1991.11 (English).
79.      Ohara SR, Hao W. Comparison on Japanese and Chinese neuroses. A cross cultural
      prospective research. The Second International Congress of Morita Therapy, Fukuoka,
      Japan, 1993 (Japanese).




                                                                                                        11
Hao Wei, MD, Ph.D.                                                                          VITA, 2002


80.      Hao W., Li LJ. Substance Abuse in China. 7th Pacific Rim of Psychiatrist Congress,
      Fukuoka, 1995 (English).
81.      Hao W., Young D. The introduction of Chinese Classification and Diagnostic Criteria
      for Mental Disorder (Second Edition), X World Psychiatry Congress, Madrid, Spain,
      1996 (English) .
82.      Hao W. Du BS. The effect of Chinese herbs in alleviating acute withdrawal symptoms
      of opiate dependence. XVI World Social Psychiatry Congress, Vancouver, 1998
      (English).
83.     Hao W. Global status of Ecstasy abuse. WHO Meeting on Psychostimulants.
      Bangkok, Thailand, 1999.11
84.       Hao W et al. Longitudinal surveys of prevalence rates and use patterns of illicit drugs
      at selected high-prevalence areas in China from 1993 to 2000 WHO/Beijing Institute on
      Substance Abuse: Prevention, Treatment Rehabilitation. Beijing, Sept. 9-13, 2002.
85.     Hao W. Alcohol use in China. First China International Symposium on Alcohol and
      Health, Shanghai, Sept. 15-18, 2002.
86.     Hao W. Medical education system in China. WHO Meeting on Mental Health
      Education and Training, Changsha, Nov., 21-26, 2002.
87.     Hao W. Do not loss hope in drug treatment and rehabilitation. The forth WHO/China
      Workshop on Addictive Behavior, Nov. 16-21, Changsha, 2003..
88.     Hao W. Alcohol abuse and mental health. First SPC/WHO Meeting on Alcohol and
      Health in the Pacific, Noumea, New Caledonia, 28-30th September 2004
89.     Hao W. WHO global activities on psychoactive substance abuse. International
      Conference on Tackling Drug Abuse, Hong Kong, 23 to 25 February 2005
90.      Hao W. Cocaine Pharmacology, toxicology, patterns of use, consequences and
      responses. International Conference on Tackling Drug Abuse, Hong Kong, 23 to 25
      February 2005.
91.     Hao W. Medical intervention on alcohol-related disorders. WHO Consultative
      Meeting on Alcohol and Public Health. Geneva, Jun. 7-9.
92.     Hao W. The molecular and cellular basis of non-dopamine system in addiction. 48th
      Annual Conference on Neurochemistry Fukuoka, Japan, Sept 28-30, 2005.
93.      Hao W. Alcohol and drug use in China: current status and trend. The Fourth Pan-Asia
      Pacific Conference on Mental Health, Shanghai, Nov. 14-17, 2005.
94.      Hao W. Alcohol use in China. Technical Consultation on the Development of a
      Strategy to Reduce Alcohol-Related Harm. 15-17 March 2006, Manila, Philippines.
95.      Hao W. Alcohol: a Legal Epidemic. 17th International Conference on the Reduction
      of Drug Related Harm. April 30-May 4, 2006, Vancouver, Canada.
96.      Hao W. China, Alcohol Today, ISBRA 2006 World Congress, Sydney, Australia,
      10-13 September 2006.
97.      Hao W. Role of quantity/frequency in alcohol abuse/harmful use dependence
      diagnoses. ISBRA Satellite Meeting, 14-15 September 2006, Sydney.




                                                                                                         12
Hao Wei, MD, Ph.D.                                                                       VITA, 2002



Chinese publications

98.       Hao W, Xu SY. Clinical pharmacology of amiodarion. Bulletin of Anhui Medical
       College. 17(3): 90-94,1982 (Chinese).
99.       Hao W, Zuo Chengye. Clinical use of antidepressant agents. Referential Journal of
       Foreign Psychiatry. 14(1): 33-37, 1987(Chinese).
100.      Hao W, Young DS. DSM-III: History and present. In: National Symposium of
       Classification and Criteria of Mental Disorders. Xinxiang, China. 1987.7(Chinese).
101.      Hao W, Young DS. Comparison on DSM-III and ICD-10. idem (Chinese).
102.      Hao W, Young DS. A double blind study of clonidine and diazepam with
       psychotherapy on smoking cessation treatment. Chinese Journal of Mental Health.
       2(2):54-58, 1988 (Chinese).
103.      Hao W, Xie DW, Ohara KS et al. Modern Morita therapy in Japan. Referential
       Journal of Foreign Psychiatry. 18(3):136-141, 1991 (Chinese).
104.      Hao W, Young DS. Multivariate prediction of the result of multicomponent approach
       smoking cessation program. Chinese Journal of Mental Health. 6(5):194-197, 1992
       (Chinese).
105.       Hao W, Opiate abuse in China: History and present. Journal of Behavioral Medicine.
       1: (2)1-5, 1992 (Chinese).
106.      Wang JK, Hao W, Zhang H. et al. Social and psychological characteristics and
       medical management on 50 heroin addicts. WHO/China Workshop on Addiction
       Behaviors. Changsha, China. 1992.11 (Chinese).
107.      Hao W. Illicit drug abuse and HIV infection. Journal of Behavioral Medicine. 2:
       12-19, 1993 (Chinese).
108.      Hao W. A multivariate evaluation of the Michigan alcoholism screening test in China.
       Chinese Journal of Mental Health. Supplement, 1993 (Chinese).
109.      Hao W. Alcohol dependence syndrome: Measurement and validation. idem
       (Chinese).
110.      Hao W. Russell smoking reason questionnaire (Chinese version): Reliability and
       validity. idem (Chinese).
111.      Pen TS, Hao W and Zhang HG . Alprazolam vs. imipramine in treatment of
       depressive neurosis. New Drugs and Clinical Remedies. 12:348-350, 1993 (Chinese).
112.      Hao W, Li LJ, Young DS et al. The gender differences and related factors in drinking
       and smoking behaviors among general population of two communities in Hunan
       Province, Chinese Journal of Clinical Psychology. 2 90-94, 1994 (Chinese).
113.      Hao W, Liu GF. AIDS and social maladaptive behaviors. Chinese Journal of
       Behavioral Medicine. 2:83-85, 1993 (Chinese).
114.      Hao W, Xie DW, Ohara KS. A case-control study on 67 patients with late-onset or
       early-onset depression. Chinese Journal of Psychiatry and Neurology Disease, 25:44-46,
       1994 (Chinese).




                                                                                                      13
Hao Wei, MD, Ph.D.                                                                          VITA, 2002


115.      Hao W, Li LJ and Xiao SY et al. An epidemiological survey of psychoactive
       substance use in two communities of Hunan Province. Chinese Journal of Mental Health.
       8:241-244, 1994 (Chinese).
116.      He Ming, Young Doung, Hao W. Monoamine release in the ventral segmental area
       and behavioral change of morphine dependent rats, Chinese Journal of Clinical
       Psychology, 3:1-6, 1995 (Chinese).
117.      He Ming, Young Doung, Hao W. Extraneuronal opioids, monoamine in the neucleus
       accumbence and POMC gene expression of morphine dependent rats, Chinese Journal of
       Mental Health, 9:1-12,1995 (Chinese).
118.     Young Doung, Hao W. Substance abuse in China, Western Pacific Region, WHO
       working meeting. Manila, Philippines, 1995 (English).
119.      He Ming, Hao W, Young Doung. Effects of buprenorphine and buprenorphine plus
       naloxone on the behavior, monoamine and opioids in CNS of morphine dependent rats.
       Journal of Clinical Psychology, 3:68-74, 1995 (Chinese).
120.      He Ming, Hao W. Effects of haloperidol and haloperidol plus electrical acupuncture
       on the behavior and CNS endogenous opioids of morphine dependent rats. Chinese
       Journal of Behavioral Medical Science. 4:8-13, 1995 (Chinese).
121.      Hao W et al. Drug reduction strategy in China. Chinese Journal of Social Medicine.
       8:44-46, 1995 (Chinese).
122.      Hao W et al. An epidemiological survey of smoking the Changsha, Harbin and
       Zhenjiang areas. Chinese Journal of Clinical Psychology, 3:205-210. 1995 (Chinese).
123.      Hao W et al. Drinking behavior in China: Present, future and strategy. Chinese
       Journal of Clinical Psychology, 3:243-248, 1995 (Chinese).
124.       Li LJ, Hao W, et al. A series of researches on quality of life in community population
       I: Conception, Chinese Journal of Mental Health, 9:136-140, 1995 (Chinese).
125.       Li LJ, Hao W et al. A series of researches on quality of life in community population
       II: The subjective and objective indicators and their relationships, Chinese Journal of
       Mental Health, 9:164-168, 1995 (Chinese).
126.      Li LJ, Hao W et al. A series of researches on quality of life (QOL) in community
       population III: Methodology and overall outcome of quality of life, Chinese Journal of
       Mental Health, 9:192-196, 1995 (Chinese).
127.      Li LJ, Hao W et al. A series of researches on quality of life in community population
       IV: Development of inventory, Chinese Journal of Mental Health, 9:200-204, 1995
       (Chinese).
128.      Li LJ, Hao W et al. A series of researches on quality of life in community population
       V: Age and QOL, Chinese Journal of Clinical Psychology, 3:84-89, 1995 (Chinese).
129.      Li LJ, Hao W et al. A series of researches on quality of life in community population
       VI: Occupation and QOL, Chinese Journal of Behavioral Science, 6:79-83, 1995
       (Chinese).
130.      Li LJ, Hao W et al. A series of researches on quality of life in community population
       VII: Living area and QOL, Chinese Journal of Social Medicine, 8:7-12, 1995 (Chinese).




                                                                                                         14
Hao Wei, MD, Ph.D.                                                                              VITA, 2002


131.       Xiao SY, Hao W, Young Doung et al. Epidemiological Study on illicit drug use in
       five selected areas in China, Part I: Demographic characteristics and prevalence, Chinese
       Journal of Mental Health, 10:234-238, 1996 (Chinese).
132.       Xiao SY, Hao W, Young Doung et al. Epidemiological Study on illicit drug use in
       five selected areas in China, Part II: Patterns of illicit drug use, Chinese Journal of
       Mental Health, 10: 278-280, 1996 (Chinese).
133.       Xiao SY, Hao W, Young Doung et al. Epidemiological Study on illicit drug use in
       five selected areas in China, Part III: Characteristics of illicit drug users, Chinese Journal
       of Mental Health, 11:51-54, 1997 (Chinese).
134.      Xiao SY, Hao W, Young Doung. Drug abuse in China: Strategies for prevention,
       Chinese Journal of Mental Health 11:124-128, 1997 (Chinese).
135.       Xiao SY, Hao W, Young Doung. Epidemiological study on illicit drug use: Some
       issues of methodology Chinese Journal of Mental Health 11:124-128, 1997 (Chinese).
136.      Zhang, DR, Wang LQ, Hao W. Opiate use in Anshun, Guizhou Province.
       Proceedings of Workshop of Behavior Medicine, Zhangjiajie, Hunan, 1994 (Chinese).
137.      Hao W. Substance abuse. Zhongyuan Journal of Psychiatry 1:109-115, 1995
       (Chinese).
138.      Hao W. Treatment of opiate dependence. Zhongyuan Journal of Psychiatry 2:46-49,
       1996 (Chinese).
139.      Hao W. Alcohol abuse related problem and treatment. Zhongyuan Journal of
       Psychiatry 2:247-253, 1996 (Chinese).
140.     Hao W, Alcohol drinking and drinking related problems in six cities in China. Ph.D.
       Degree Paper, (Chinese).
141.      Wu L, Hao W. The impact of morphine on immunocompetence of mice, Chinese J of
       Clinical Psychology, 5:193-197, 1997
142.      Wu L, Hao W. The impact of heroin on human cytoimmunity and its mechanism,
       Chinese Journal of Psychiatry, 31:166-168, 1998
143.      Hao W, Young D., Alcohol drinking and drinking related problems in six cities in
       China. Part I. Methodology and drinking rate. Chinese Journal of Clinical Psychology.
       6:65-70, 1998. (Chinese).
144.      Hao W, Young D., Alcohol drinking and drinking related problems in six cities in
       China. Part II. Drinking related problems in general population. Chinese Journal of
       Clinical Psychology. 6:152-155, 1998. (Chinese).
145.      Hao W, Young D., Alcohol drinking and drinking related problems in six cities in
       China. Part III. Drinking related problems in population with special occupations.
       Chinese Journal of Clinical Psychology 6:199-202, 1998. (Chinese).
146.      Hao W, Young D., Alcohol drinking and drinking related problems in six cities in
       China. Part IV. The risk factors of alcohol dependence. Chinese Journal of Clinical
       Psychology 7:4-12, 1999. (Chinese).
147.       Zhang RL, LI LJ, Hao W. Neurobiological mechanisms of stress in drug action and
       relapse. Chinese Journal of Clinical Psychology 8:61-65, 2000.
148.      Liu TQ, Wang XP, Hao W. Frequency of withdrawal symptoms of Natural
       Detoxification in heroin addicts. Chinese Journal of Mental Health 14:114-116, 2000.


                                                                                                             15
Hao Wei, MD, Ph.D.                                                                       VITA, 2002


149.      Hao W. MDMA abuse in the world. Chinese Journal of Drug Dependence. 9:249-251,
       2000.
150.      Chen HX, Hao W. The biological mechanism of opiate dependence. Chinese Journal
       of Drug Dependence, 9:97-101, 2001, (Chinese).
151.      Geng T, Hao W. The application of drug assessment of capillary electrophoresis.
       Chinese Journal of Drug Dependence, 10:161-164, 2001, (Chinese).
152.       Fan CH, Hao W. The new development of methodology on epidemiological survey
       of illicit drug. Chinese Journal of Clinical Psychology, 9:115-118, 2001. (Chinese).
153.      Shen HX, Hao W. The connection between CPP and dopamine level of nucleus
       accumbens of morphine dependent rats in withdrawal status. Chinese Journal of Drug
       Dependence, 10: 97-100, 2001. (Chinese).
154.      Zhao M Hao W. Associations between heroin dependence and dopamine D5 and
       5-HT2C receptor genes. Chinese Journal of Behavioral Medical Science. 10:412-414,
       2001.
155.      Zhao M, Hao W. Psychiatric comorbidity among heroin dependent patients. Chinese
       Journal of Drug Dependence 10:192-194, 2001
156.      Zhao M, Hao W. Follow-up study on the abstinent rates in heroin ex-addicts in a
       correctional camp by using TC philosophy and method, Chinese Journal of Drug
       Dependence, 9:213-216, 2000, (Chinese).
157.      Hao W. Chen XG. Mental health: new understanding, new hope, A brief introduction
       of World Health Report, 2001. Foreign Medical Sciences, Section of Psychiatry. 29:1-5,
       2002.
158.     Hao W, Xiao SY, Young D. The second epidemiological survey on illicit drug, part I.
       Methodology, prevalence rates and the time of initial use. Chinese Journal of Mental
       Health 16:227-229, 2002 (Chinese).
159.      Hao W, Xiao SY, Young D. The second epidemiological survey on illicit drug, part II.
       Use patterns of illicit drugs. Chinese Journal of Mental Health 16:224-226, 2002.,
       (Chinese).
160.       Hao W, Xiao SY, Young D. The second epidemiological survey on illicit drug, part
       III. The demographic features of illicit drug users. Chinese Journal of Mental Health
       16:219-223, 2002.
161.       Liu TQ, Hao W, Wang XP et al. A survey on recreational amphetamine type
       stimulants: demographics and use patterns. Chinese Journal of Mental Health. 16:
       289-292, 2002.
162.       Liu TQ, Hao W, Wang XP et al. A Survey on recreational amphetamine type
       stimulants: negative consequences. Chinese Journal of Mental Health. 16: 293-295,
       2002.
163.      Hao W. Liu TQ, Wang XP et al. Social demographics, use patterns and negative
       consequences of 237 cases with instrumental amphetamine typed stimulants. Chinese J
       of Psychiatry, 35:27-31, 2002. (Chinese).
164.     Zhang RL., Hao W. Glutaminergic system in CNS and opiate dependence. Foreign
       Medical Sciences, Section of Psychiatry. 29: 241-245, 2002.




                                                                                                      16
Hao Wei, MD, Ph.D.                                                                          VITA, 2002


165.      Zhang RL., Hao W. Opiate dependence and brain gene express. Chinese Journal of
       Drug Dependence. 11: 241-244, 2002. (Chinese)
166.      Zhang RL., Hao W. Li CQ. et al. Regulation of synapsin I mRNA in different brain
       region of rats during chronic morphine treatment and withdrawal. Chinese Journal of
       Drug Dependence. 12:16:20, 2003. (Chinese)
167.       Hao W., Zhang RL Cheng HX. et al. Changes of adenylate cyclase VIII expression in
       rat brain regions at different time points after chronic morphine exposure. Chinese J
       Psychiatry. 36: 176-179, 2003. (Chinese)
168.      Hao W. The mechanism of rewards in CNS. Chinese Journal of Drug Prevention and
       Treatment. 9:54-57, 2003. (Chinese)
169.      Zhang RL, Hao W, Cheng Hongxian et al. Inhibitory effects of dizocilpine on
       morphine-induced conditioned place preference and withdrawal signs in rats. Chinese
       Journal of Behavioral Medical Science 12: 128-130, 2003. (Chinese)
170.      Chen HX, Hao W, Young DS, et al. The development of protracted withdrawal
       symptoms of opiate dependence. Chinese Mental Health Journal 17: 294-197, 2003.
       (Chinese)
171.      Xiang XJ, Hao W. The blood alcohol level limitation of drinking driver. Chinese
       Journal of Drug Dependence. 12:169-172, 2003. (Chinese)
172.      Li LJ, Yang DS., Zhou L, Hao W. et al. The validity and reliability of the World
       Health Organization Quality of Life questionnaire in chronic patient and family
       caregivers. Chinese Journal of psychiatry 36:143-147, 2003. (Chinese)
173.     Xiang XJ, Hao W. Drinking in 560 emergency cases. Chinese Journal of Drug
       Dependence 12:284-288, 2003. (Chinese)
174.       Fan CH, Hao W, Young DS. The third epidemiological survey on illicit drug use in 6
       selected high prevalence areas in China Chinese Journal of Drug Dependence12:
       288-293, 2003. (Chinese)
175.       Su ZH, Hao W, Chen HX et al. Alcohol drinking and drinking related problems in
       five areas in China. Part I. Drinking related problems in general population Chinese
       Journal of Clinical Psychology 17:536-539, 2003 (Chinese).
176.       Su ZH, Hao W, Chen HX et al. Alcohol drinking and drinking related problems in
       five areas in China. Part II. The health status of drinkers Chinese Journal of Clinical
       Psychology 17:540-543, 2003 (Chinese).
177.       Su ZH, Hao W, Chen HX et al. Alcohol drinking and drinking related problems in
       five areas in China. Part III. The health status in general population. Chinese Journal of
       Clinical Psychology 17:544-546 (Chinese).
178.      Yue WH, Hao W. Liu PZ. The cognitive function in patients with sleep
       apnea-hypopnea syndrome apea. Foreign Medical Sciences, Section of Psychiatry
       30:24-27, 2003. (Chinese)
179.      Hao W. The efficacy of atypical antipsychotic drugs in the treatment of refractory
       depression and anxiety disorders. Journal of Evaluation and Analysis of drug use in
       Hospitals of China. 3:317-318, 2003. (Chinese)
180.      Yue WH, Liu PZ, Hao W et al. The study of sleep structure and hypoxemia in 78
       patients with sleep apnea syndrome. Chinese Journal of Clinical Psychology 12: 74-73,
       2004. (Chinese)


                                                                                                         17
Hao Wei, MD, Ph.D.                                                                           VITA, 2002


181.      Wang XY, Liu TQ and Hao W. Advance in molecular biology research on alcohol
       dependence Chinese Journal of Clinical Psychology 12: 107-110, 2004. (Chinese)
182.      Fan CH, Hao W, Yang DS. Nomination method used in a nationwide epidemiological
       survey on illicit drug use in China. Chinese Journal of Behavioral Medical Science 13:
       50-51, 2004. (Chinese)
183.      Wu ZG, Su ZH, Hao W. Demographic characteristics and related factors of alcohol
       dependence in five areas in China. Chinese Journal of Behavioral Medical Science 13:
       52-54, 2004 (Chinese)
184.      Chen HX, Hao W., Liu TQ. et al. A control study on clinical efficacy of Chinese
       herbal compounds, Anjunning and Kangfuxin on alleviating opiate protracted abstinent
       symptoms Chinese Journal of Clinical Psychology 12: 38-40, 2004. (Chinese)
185.      Zhang RL. Hao W. Chen HX et al. Effect of dizocipine on gene expression of
       adenylyl cyclase VIII in selected brain regions of morphine dependent rats. Chinese
       Journal of Behavioral Medical Science 13: 148-149, 2004 (Chinese)
186.      Jiang MJ. Hao W. Zhang XG. Coping styles, social support and parental rearing
       behavior in heroin addicts. Chinese Journal of Clinical Psychology 12: 198-200, 2004.
187.      Yue WH. Hao W. Liu PZ et al. Memory changes in patients with sleep apnea
       syndrome. Chinese Journal of Psychiatry. 37:168-171, 2004.
188.      Li Y., Hao W. Zhang ZX et al. The comparison of CSF levels of beta-amyloid
       peptide1-42 in patients with Alzheimer‟s disease and vascular dementia. Chinese Journal
       of Clinical Psychology 2004, 12:269-271, 2004.
189.      Hao W. Illicit drug use in China: situation and strategy for control. Chinese Journal of
       Drug Dependence. 2004 ,13 :227 – 230
190.      Li W., Hao W., Su ZH., The Alexithymia and family characteristics in female patients
       with heroin dependence. Chinese Journal of Mental Health. 2005,19, (3): 147-149.

191.      Li W., Hao W., Su ZH. The cognitive characteristic in female inmate with heroin
       dependence in Correction Institutions. Chinese Journal of Clinical Psychology. 2004, 12
       (4): 408-419, 413.

192.      Liu BL, Hao W, Young DS. The status and problems in the studies of Internet
       addiction. Foreign Medical Sciences, Section of Psychiatry 2004, 31: 199-202.
193.      Li Y., Hao W. The conditioned place aversion (CPA) after withdrawal of long-term of
       substance use. Foreign Medical Sciences, Section of Psychiatry 2004, 31: 205-208.
194.     Su ZH, Hao W. The methodology of alcohol-related cognitive damage. Foreign
       Medical Sciences, Section of Psychiatry 2005, 32: 49-51.
195.      Yang FR, Hao W. The effect of integrated psychosocial intervention on 52
       adolescents with internet addiction disorder. Chinese Journal of Clinical Psychology 200,
       13:343-346.
196.       Chen HX, Hao W, Lui TQ et al. The influence of Anjunning, a herb medicine
       compound, on pre-proenkephalin expression some brain region of morphine dependent
       rats. Chinese Journal of Behavioural Medical Science. 2005, 14:1063-1065.
197.      Li W, Su ZH, Hao W. et al. Analysis of depression characteristics and the related
       factors in male patients with heroin dependence. Chinese Journal of Behavioural Medical
       Science. 2005, 14:1071-1073.


                                                                                                          18
Hao Wei, MD, Ph.D.                                                                         VITA, 2002


198.      Yang FR. Hao W. Study on reason, consequence and intervention in the Adolescents
       with Internet Addiction Disorder. Practical Preventive Medicine, 2005, 4:965-967.
199.      Xiang XJ. Hao W. Zhou XH. et al. Effect of acute stress and acute morphine
       exposure on spatial memory in rats of different ages. Chinese Journal of Clinical
       Psychology 2006, 14: 209-212.
200.      Chen HX. Hao W. Liu TQ. The impact of Anjunning, a Chinese herb compound, on
       pre-pre-opiomelanocortin mRNA expression in nucleus accumbens of morphine
       dependent rats. Chinese Journal of Clinical Psychology 2006, 14: 212-214.
201.      Wang XY, Hao W, Li W. A control study of selective attention in patients with heroin
       dependence. Chinese Journal of Behavioural Medicine Science. 2006, 15: 326-327.
202.      Zhou XH, Su ZH, Deng HQ, Hao W. The drinking and smoking behaviour in the
       general population of urban and rural areas in the Huahua district, Hunan Province,
       China. Chinese Journal of Behavioural Medicine Science,2006, 15: 352-355.

203.      Wang XY., Hao W. A progress in the research of functional imaging on drug
       addiction, Chinese Journal of Drug Dependence.2006, 15: 9-12.
204.      Zheng ZY, Zheng YL, Hao W. Social cost estimate of alcohol use. Chinese Journal of
       Drug Dependence. 2006, 15: 13-16.
205.      Zheng DK., Zhou XH., Zhang XH., Hao W. et al. A survey on buprenorphine plus
       scopolamine and promethazine abuse in Changsha, China. Chinese Journal of Drug
       Dependence,2006, 15:53-56

206.      Hao W., Xiang XJ., Cui MH., Chen HX. The study of impact of stress and
       environment on electrophysiology and behaviour changes in morphine exposed rats.
       Chinese Journal of Drug Dependence. 2006, 15: 187-191.
207.      Liu BL, Hao W., Yang DS et al. Development of diagnostic scale for internet
       addiction disorder by using item response theory. Chinese Journal of Clinical
       Psychology, 2006, 14: 227-230.
208.      Li Y., Hao W., Wang XY et al. Developing the conditioned place aversion rat model
       produced by naloxone-precipitated withdrawal from chronic morphine dependence.
       Chinese Journal of Clinical Psychology, 2006, 14: 275-277.
209.      Wang XY., Hao W., Yan LR et al. The brain functional changes in heroin dependent
       patients at conscious resting state after withdrawal ----a fMRI research. Chinese Journal
       of Clinical Psychology, 2006, 14: 428-430.
210.      Xiang XJ., Hao W., Deng HQ. et al. Effects of chronic stress and acute morphine
       exposure on spatial memory in rats of different ages. Chinese Journal of Clinical
       Psychology, 2006, 14: 431-434.
211.      Chen HH, Hao W., Chen HX et al. Effect of intra-accumbens injecting protein kinase
       on morphine-produced conditioned place preference in rats, Chinese Journal of Drug
       Dependence 2006, 15:353-357.
212.      Jiang SA,, Wang XY., Hao W. Controlled study of cerebral gray matter concentration
       in patients with heroin dependence, Chinese Journal of Drug Dependence 2006,
       15:373-375.
213.      Hao W. The biological mechanism of psychoactive substance abuse. MD Weekly,
       2007.2.15



                                                                                                        19
Hao Wei, MD, Ph.D.                                                                          VITA, 2002


214.      Li W, Hu CF., Hao W. Relationship between memory and oxidative stress in patients
       with heroin dependence. Journal of Clinical Psychiatry 2007, 17:1-3.
215.      Su ZH, Zbou XH, Chen HX and Hao W. The survey on opiate abuse at six area in
       Hunan Province, Part I: methodology, social characteristics of the sample, prevalent rates
       and time of first and last use. Chinese Mental Health Journal, 2007, 21: 142-146.
216.      Su ZH, Zbou XH, Chen HX and Hao W. The survey on opiate abuse at six area in
       Hunan Province, Part II: use patterns and demographical characteristics of opiate
       abusers.. Chinese Mental Health Journal, 2007, 21: 147-150.
217.      Li W, Hao W, Hu CF et al. Cognitive deficits and oxidative stress in male patients
       with heroin dependence. Chinese Mental Health Journal, 2007, 21: 151-154.
218.      Hao W. Cao D. Yu X. Drinking and drinking-related problems in China. Chinese
       Journal of Drug Dependence. 2007,16:193-197.
219.      Jiang MJ., Su ZH., Liu XB., Hao W. Effect of morphine and L-NAME on the
       expression of iNOS mRNA. Chinese Journal of Behavioral Medical Science 2007,
       16:583-585.
220.      Hao W. The status of illicit drug use and related strategy. MD Weekly, 2007.9.6
221.      Wang YH, Yu JL, Huang JS, Hao W. et al. Effects of low frequency
       electroacupuncture at Su San-Li on ethanol taking behavior in ethanol dependent rats.
       Chinese Mental Health Journal. 2008, 22:157-163.
222.      Wang YH, Li WQ, Huang Z et al. 5-HT2A receptor gene polymorphism and negative
       symptoms in first episode (drug-naïve) Chinese Han nationality individuals with
       schizophrenia. Journal of Central South University (Medical Science) 2008, 33: 293-296.
223.      Wang YH, Zeng LB, Liu YJ, Hao W et al. Effect of electroacupuncture on
       drug-seeking behaviors induced by heroin priming and FosB expression in relevant brain
       regions. Journal of Central South University (Medical Science), 2008, 33:299-304.
224.       Zhang DK, Su QR, Hao W. et al. Morphine withdrawal decrease the glucose
       self-administration of rat. Chinese Pharmacological Bulletin, 2008, 24(11): 1537-1539
225.     Zhou XH, Wang XY, Hao W. A Review of Functional Imaging in Nicotine
       Dependence 2007, 15, 489-491
226.      Zhang DK, Hao W, Zhou XH. The explanation to the result of self-administration
       experiment. Chinese Journal of Drug Dependence. 2007, 2007, 16 (2) : 87 – 90
227.      Zhou XH, Huang JS, Zhang DK., Hao W. A case report to iv combination of
       buprenorphine, scopolamine and promethazine., Chinese Journal of Drug Dependence.
       2007, 16, 400
228.       He Zhong, Zhou XH, Wang XY, Liu J, Hao W. Longitudinal study on Brain Structure
       in the Heroin Dependence Patients During Abstinence,Chinese Mental Health Journal.
       2008, 16,358-360

229.      Huang JS, Wang YH, Zhou XH, Hao W. The Effectiveness of Buprenorphine in
       Combination with Scopolamine and Promethazine on Spatial Memory in SD Rats.
       Chinese Journal of Clinical Psychology 2008, 16, 151-153.
230.      Wang YH, Li WQ, Huang Z. Zhi YZ Hao W. 5- HT2A receptor gene polymorphism
       and negative symptoms in the first episode ( drug-naive ) Chinese Han nationality



                                                                                                         20
Hao Wei, MD, Ph.D.                                                                         VITA, 2002


       individuals with schizophrenia. Journal of Central South University (Medical Science),
       2008, 33, 392-394
231.     Hao W. Tobacco dependence is a chronic additive disease. Chinese Journal Internal
       Medicine, 2008, 47: 523-525.
232.      Wang CS, Chen HX, Hao W. Novel environmental response and heroin-dependent
       susceptibility in Sprague-Dawley rats. Journal of Central South University (Medical
       Science). 2009, 34:277-281.
233.      Song L, Hao W, Cui TT et al. Effect of morphine addiction and withdrawal in parents
       prior to mating on the anxiety-like behavior and spatial learning-memory in adult
       offspring rats. Chinese Journal of Behavioral Medicine and Brain Science. 2009,
       18:519-522.
234.      Cao D, Cao J, Hao W, Xu L. Hippocampal Combinatorial Plasticity Induced by
       Conditioning of Converging Schaffer-CA1 Pathways in Rat in vivo. Zoological Research
       2009, 30(4):396-400.
235.      Tang QS, Hao W., Zhou ZN et al. The efficacy of modified Morita Therapy on the
       abnormal personality of patients with psychosis in the rehabilitation. Chinese Journal of
       Behavioral Medicine and Brain Science. 2009, 18:615-617.
236.      Wang CS, Chen HX., Hao W. Dopamine D2 receptor and transporter in the shell
       accumbens nucleus of heroin-induced conditioned place preference in SD rats. Chinese
       Journal of Clinical Psychology 2009, 17:566-569.
237.      Yang M, Hao W. personality disorders and psychological characteristics in 70 male
       heroin dependent patients. 2009, 18:491-494.
238.       Zhang DK, Hao W, Zhou XH et al. Effects of terguride on protein and mRNA
       expressions of dopamine D2 receptor and dynorphin in different brain regions of rats
       after heroin self administration. Chinese Journal of Pharmacology and toxicology. 2010,
       24:13-18.




                                                                                                        21

								
To top